AlphaSize A-GPC brain-health and muscle-support ingredient now non-GMO verified, says Chemi Nutra

Photo © AdobeStock.com/monsitj

AlphaSize alpha-glyceryl phosphoryl choline (A-GPC), an ingredient recognized in the cognitive health, sports nutrition, and healthy aging supplements market, has earned non-GMO certification by the International GMO Evaluation and Notification Program (IGEN), says AlphaSize’s supplier Chemi Nutra (Austin, TX).

IGEN certification was developed by testing laboratory Nutrasource Diagnostics Inc. (Guelph, ON, Canada), which the lab describes as “the only third-party testing and certification program that evaluates the presence or absence of genetically modified organisms (GMOs) in products and the ingredients used to make them, using validated analytical methods.”

Scott Hagerman, president of Chemi Nutra, said in a company press release: “We selected the IGEN program because we were very impressed with the testing integrity this organization provides and stands behind. Verification assures our customers that our specialty AlphaSize A-GPC ingredient products have been thoroughly tested by a certified third party and that our customers as well as final consumers can be assured of our complete transparency, demonstrating the lack of GMOs.”

Chemi Nutra says AlphaSize A-GPC is the only branded A-GPC ingredient with a Generally Recognized as Safe dossier submitted to FDA for review. And, the company says, unlike some generic, synthetic A-GPC ingredients that are manufactured using “genotoxic raw materials” and which most likely are not recognized as legal dietary supplement ingredients under the Dietary Supplement Health and Education Act (DSHEA) in the United States, Alpha-Size APC is 100% natural and made without any synthetic chemicals.

A-GPC has gained a reputation as a dietary supplement ingredient, including for cognitive and muscular support. AlphaSize’s highly bioactive component is choline, which Chemi Nutra describes as playing a “critical role in liver function, brain development, muscle movement, nervous system function, and metabolism.”

“Numerous published papers state that A-GPC is considered the most active of choline-containing phospholipids in increasing acetylcholine levels in the brain (cognitive functioning) and in motor units that activate fast muscle contraction (power and strength),” Chemi Nutra explains. For a refresher on A-GPC and phospholipid ingredients, click here. Alpha-Size A-GPC has been studied in dozens of published human studies for its mental and physical performance benefits, Chemi Nutra says.

“AlphaSize A-GPC is rapidly absorbed as choline and readily crosses the blood-brain barrier,” the company says. “In contrast, there are several published studies demonstrating that common choline salts, choline chloride, and choline bitartrate are not effective in brain metabolism as detected by proton magnetic resonance spectroscopy (MRS) and had no effect on memory in healthy, young human adults."

AlphaSize A-GPC is said to be 100% water soluble, tasteless, and odorless and “extremely stable and nonreactive” in a variety of products, including beverages, shots, bars, chewing gum, gummies, food, and pet supplements.

“Nearly 20 years ago, Chemi Nutra introduced our branded AlphaSize A-GPC to the supplement industry, and it is proven safe and legal for use, unlike synthetic A-GPC, and is patented and produced in our own plant in Italy,” said Hagerman, noting the plant of parent company Chemi S.p.A. (Milan). “In fact, I am not aware of any other A-GPC brand ever being investigated in any study, let alone having published safety studies, being fully FDA GRAS, and having a long history of safe use.”

Chemi Nutra Hires Sales Manager

In other company news, Chemi Nutra announced recently that it has hired a new sales manager, Alfredo “AI” Reyna. Reyna will focus on growing the company’s U.S. and global business. His background is in the health and hospice field, where, the company says, he “saw firsthand that alternative, complementary, and nutritional supplement intervention played an increasing role in this health sector.”